Filtros de búsqueda

Lista de obras de

A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma ⬇️

artículo científico publicado el 25 de octubre de 2010

A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer ⬇️

artículo científico publicado el 11 de octubre de 2010

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer

artículo científico publicado en 2003

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

scientific article published on 24 May 2019

Activation of the Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Overcomes Cisplatin Resistance in Ovarian Carcinoma Cells ⬇️

artículo científico publicado el 1 de julio de 2012

Activity of docetaxel in paclitaxel-resistant ovarian cancer cells ⬇️

artículo científico publicado el 11 de noviembre de 2003

Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.

artículo científico publicado en 2007

Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary

artículo científico publicado en 2006

An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with beva

artículo científico publicado en 2018

Apparent diffusion coefficient (ADC) measurement in endometrial carcinoma: effect of region of interest methods on ADC values

artículo científico publicado en 2013

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

scientific article published on 25 September 2013

Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies ⬇️

artículo científico publicado el 18 de mayo de 2012

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study

artículo científico publicado en 2020

Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary

artículo científico publicado en 2014

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group

artículo científico publicado en 2017

Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube

artículo científico publicado en 2008

Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.

artículo científico publicado en 2017

Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma

artículo científico publicado en 2011

Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group ⬇️

artículo científico publicado el 17 de octubre de 2012

Clinical trials and future potential of targeted therapy for ovarian cancer ⬇️

artículo científico publicado el 28 de agosto de 2012

Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers

artículo científico publicado en 2004

Clinicopathological characteristics of mucinous adenocarcinoma of the ovary

artículo científico publicado en 2009

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy

artículo científico publicado en 2008

Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance

artículo científico publicado en 2013

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

artículo científico publicado en 2014

Correlation of apparent diffusion coefficient value with prognostic parameters of endometrioid carcinoma

artículo científico publicado en 2013

Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging

artículo científico publicado en 2007

Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions

artículo científico publicado en 2008

Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results

artículo científico publicado en 2007

Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas

artículo científico publicado en 2010

Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary

artículo científico publicado en 2014

Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells

artículo científico publicado en 2002

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene

artículo científico publicado en 2013

Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2 ⬇️

artículo científico publicado el 30 de diciembre de 2012

Evaluation of a formula for individual dosage of nedaplatin based on renal function

scientific article published on 15 September 2011

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

artículo científico publicado en 2010

Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer

artículo científico publicado en 2004

Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy

artículo científico publicado en 2016

Feasibility Study on Biweekly Paclitaxel Treatment as Maintenance Chemotherapy in Advanced Müllerian Carcinoma ⬇️

artículo científico publicado el 1 de enero de 2012

Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer

artículo científico publicado en 2006

Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer

artículo científico publicado en 2016

Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach

artículo científico publicado en 2015

Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma

artículo científico publicado en 2008

Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architecture

artículo científico publicado en 2012

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia

artículo científico publicado en 2015

Hydrotubation for diagnosing carcinoma in situ of the fallopian tube. A case report

artículo científico publicado en 2002

Identification of potential serum markers for endometrial cancer using protein expression profiling

artículo científico publicado en 2009

Impact of Histopathological Risk Factors on the Treatment of Stage IB-IIB Uterine Cervical Cancer

scientific article published on 01 December 2020

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer

artículo científico publicado en 2017

Implementation of primary HPV testing in Japan

scientific article published on 16 July 2020

Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy

artículo científico publicado en 2014

Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide through Upregulation of c-Jun ⬇️

artículo científico publicado el 24 de mayo de 2011

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

artículo científico publicado en 2005

Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells

artículo científico publicado en 2003

Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

artículo científico publicado el 1 de diciembre de 2010

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

artículo científico publicado en 2015

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

artículo científico publicado en 2002

MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model

artículo científico publicado en 2011

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

artículo científico publicado en 2008

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

artículo científico publicado en 2002

Molecular targeted therapies for epithelial ovarian cancer

artículo científico publicado el 1 de junio de 2012

Molecular-targeted therapies for ovarian cancer

artículo científico publicado en 2012

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer

artículo científico publicado en 2002

Myometrial invasion by endometrial carcinoma: evaluation with 3.0T MR imaging ⬇️

artículo científico publicado el 1 de octubre de 2011

Nedaplatin: a cisplatin derivative in cancer chemotherapy ⬇️

artículo científico publicado el 8 de mayo de 2013

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival

scientific article published on 30 January 2019

Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix

artículo científico publicado en 2016

New strategy for overcoming resistance to chemotherapy of ovarian cancer.

artículo científico publicado en 2013

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27 ⬇️

artículo científico publicado el 8 de junio de 2011

Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study ⬇️

artículo científico publicado el 24 de octubre de 2011

Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy

artículo científico publicado en 2013

Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman

artículo científico publicado en 2003

Ovarian metastasis in carcinoma of the uterine cervix

artículo científico publicado en 2005

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

scientific article published on 01 August 2002

PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells

artículo científico publicado en 2005

PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma

artículo científico publicado en 2005

Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study

artículo científico publicado en 2014

Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-base

artículo científico publicado en 2008

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

artículo científico publicado en 2020

Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer

artículo científico publicado el 1 de diciembre de 2010

Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study

artículo científico publicado en 2009

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers

artículo científico publicado en 2006

Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancer

artículo científico publicado en 2009

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

artículo científico publicado en 2007

Pseudo-Meigs' syndrome caused by retroperitoneal tumor in a patient with Ebstein anomaly

artículo científico publicado en 2005

Questionnaire survey of the current status of radical trachelectomy in Japan ⬇️

artículo científico publicado el 19 de noviembre de 2010

Relationship Between ABCF2 Expression and Response to Chemotherapy or Prognosis in Clear Cell Adenocarcinoma of the Ovary ⬇️

artículo científico publicado el 1 de julio de 2010

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary

artículo científico publicado en 2002

Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma

artículo científico publicado en 2007

Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma

artículo científico publicado en 2015

Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer

scientific article published on 01 June 2004

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma

artículo científico publicado en 2014

The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer

artículo científico publicado en 2005

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)

scientific article published on 01 July 2019

The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study

artículo científico publicado en 2009

Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer

artículo científico publicado en 2002

Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer

scientific article published on 03 January 2005

Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group

artículo científico publicado en 2011

What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

artículo científico publicado en 2015

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.

artículo científico

[Lymphadenectomy for cervical cancer: indications and limits]

artículo científico publicado en 2004

[PTEN expression in endometrial cancer and the prognosis]

scientific article published on 01 October 2004

[Preservation of organic function in surgery for cervical cancer]

artículo científico publicado en 2004

[Review and revision of guidelines for ovarian cancer treatment in Japan]

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda